Search Results 541-550 of 17854 for Embolism

  1. Moyamoya disease - Doctors and departments - Mayo Clinic

    ... embolism, Respiratory failure, Shock, Septic shock, Hemorrhagic shock. Show more areas of focus for Miguel T. Teixeira, M.D.. Moyamoya research.

  2. Clinical trials - Oncology (Medical)

    ... embolic load. The Patient Group 2 primary objectives are to assess the association of circulating and imaging biomarkers on Future Liver Remnant hypertrophy ...

  3. Abdominal aortic aneurysm - Doctors and departments - Mayo Clinic

    ... embolism. Show more areas of focus for Sam Farres, M.D.. Research. Publications. See a list of publications about abdominal aortic aneurysms by Mayo Clinic ...

  4. Abdominal aortic aneurysm - Doctors and departments - Mayo Clinic

    ... embolism. Show more areas of focus for Sam Farres, M.D.. Research. Publications. See a list of publications about abdominal aortic aneurysms by Mayo Clinic ...

  5. Sharing Mayo Clinic: COVID-19 setback right before brain surgery

    IVC filters help reduce the risk of pulmonary embolism by trapping large clots before they can reach the heart, lungs or brain. In Julie's case, this was ...

  6. Publications - Sailendra G. Naidu, M.D. - Mayo Clinic

    Air Embolism: Diagnosis, Clinical Management and Outcomes. Diagnostics (Basel). 2017 Jan 17; 7 (1) View PubMed; Behravesh S, Hoang P, Nanda A, Wallace A ...

  7. Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE - Mayo Clinic

    Acute pulmonary embolism within 90 days of randomization. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...

  8. Norethindrone, ethinyl estradiol, and ferrous fumarate (oral route) - Mayo Clinic

    Other Medical Problems · Abnormal or unusual vaginal bleeding or · Blood clots (eg, deep vein thrombosis, pulmonary embolism), or history of or · Breast cancer, ...

  9. Moyamoya disease - Doctors and departments - Mayo Clinic

    ... embolism, Respiratory failure, Shock, Septic shock, Hemorrhagic shock. Show more areas of focus for Miguel T. Teixeira, M.D.. Moyamoya research.

  10. Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease - Mayo Clinic

    Treatment or secondary prevention of deep venous thrombosis and pulmonary embolism. Exclusion Criteria: Significantly elevated risk of bleeding, including ...